Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BIO Bio-Rad Laboratories, Inc. daily Stock Chart
BIO [NYSE]
Bio-Rad Laboratories, Inc.
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E34.39 EPS (ttm)10.55 Insider Own1.90% Shs Outstand29.69M Perf Week3.10%
Market Cap10.77B Forward P/E41.95 EPS next Y8.65 Insider Trans-1.73% Shs Float21.50M Perf Month5.62%
Income327.70M PEG1.75 EPS next Q2.43 Inst Own79.40% Short Float1.90% Perf Quarter6.11%
Sales2.30B P/S4.68 EPS this Y502.10% Inst Trans4.77% Short Ratio1.94 Perf Half Y23.43%
Book/sh172.01 P/B2.11 EPS next Y20.56% ROA5.50% Target Price390.00 Perf Year35.19%
Cash/sh32.98 P/C11.00 EPS next 5Y19.60% ROE7.70% 52W Range220.05 - 366.03 Perf YTD56.25%
Dividend- P/FCF39.56 EPS past 5Y31.20% ROI-6.60% 52W High-1.75% Beta1.16
Dividend %- Quick Ratio3.40 Sales past 5Y1.40% Gross Margin54.80% 52W Low63.44% ATR7.29
Employees8260 Current Ratio4.70 Sales Q/Q2.80% Oper. Margin-2.60% RSI (14)58.73 Volatility1.71% 2.44%
OptionableYes Debt/Eq0.09 EPS Q/Q-197.60% Profit Margin16.30% Rel Volume0.73 Prev Close362.84
ShortableYes LT Debt/Eq0.09 EarningsOct 31 AMC Payout0.00% Avg Volume209.91K Price359.64
Recom1.50 SMA202.94% SMA505.29% SMA20014.35% Volume57,619 Change-0.88%
Oct-17-18Initiated Goldman Buy $350
Sep-20-18Initiated Morgan Stanley Equal-Weight $335
Feb-16-18Downgrade CL King Buy → Neutral
Jul-13-17Initiated Wells Fargo Outperform
Jun-28-17Upgrade Deutsche Bank Hold → Buy $220 → $255
Jan-18-17Initiated Deutsche Bank Hold $195
Oct-13-16Initiated CL King Buy
May-06-15Reiterated Jefferies Buy $150 → $165
Dec-18-09Initiated Maxim Group Buy $125
Nov-06-09Initiated Jefferies & Co Buy $130
Jul-17-09Initiated Soleil Buy $91
Sep-26-07Initiated Banc of America Sec Buy $110
Feb-23-07Downgrade Robert W. Baird Outperform → Neutral $83 → $76
Nov-18-19 01:17AM  Edited Transcript of BIO earnings conference call or presentation 31-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
Nov-11-19 07:49AM  Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? Simply Wall St.
Nov-01-19 12:03PM  Bio-Rad (Bio) Q3 Earnings Beat Estimates on All-Line Growth Zacks +6.25%
Oct-31-19 06:15PM  Bio-Rad Laboratories (BIO) Q3 Earnings Beat Estimates Zacks
04:15PM  Bio-Rad Reports Third-Quarter 2019 Financial Results Business Wire
Oct-29-19 05:09PM  This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks Insider Monkey
Oct-24-19 10:32AM  Bio-Rad Laboratories (BIO) Earnings Expected to Grow: Should You Buy? Zacks
Oct-23-19 11:13AM  5 Companies Hit 52-Week Highs GuruFocus.com
Oct-16-19 04:15PM  Bio-Rad to Report Third-Quarter 2019 Financial Results Thursday, October 31, 2019 Business Wire
Oct-15-19 12:05PM  5 Stocks to Buy in the Mighty Middle InvestorPlace
Oct-12-19 03:34PM  Heres What Hedge Funds Think About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Oct-08-19 10:36AM  LabCorp (LH) Names Two Leaders for Major Business Wings Zacks -5.55%
Oct-07-19 06:36AM  Bruker To Buy Freiberg Instruments' Magnettech EPR Business Zacks
Oct-02-19 09:48AM  Abbott (ABT) Gets FDA Nod for New Troponin-I Blood Test Zacks
Oct-01-19 05:10PM  It's not just Google: 'Fierce' competition for tech talent is pushing median salaries past $200K at many Silicon Valley companies American City Business Journals
Sep-18-19 09:07AM  Goldman Sachs: 4 Conviction Buy Stocks To Snap Up Now TipRanks
Sep-12-19 05:28PM  After record IPO, East Bay company's CEO targets growth and sleep American City Business Journals
09:55AM  On eve of biggest biotech IPO this year, 2 East Bay companies spar over patents American City Business Journals
Sep-11-19 05:48PM  Bio-Rad Files New Lawsuit Against 10X Genomics for Patent Infringement Business Wire
Aug-31-19 09:31AM  Bio-Rad (BIO) Up 8.8% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 06:13PM  Biome Sees Revenue Quadruple, Gross Profits Triple In Q2 Benzinga
03:20PM  Edited Transcript of BIO earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-23-19 06:51AM  Here's Why You Should Retain Bio-Rad (BIO) Stock for Now Zacks
Aug-21-19 06:56PM  Fitch Ratings Upgrades Bio-Rad to BBB, Outlook Stable, Reflecting Continued Improvement in the Companys Operating Performance Business Wire
Aug-19-19 05:45PM  How a biotech revolution catapulted this East Bay company to a $100M IPO American City Business Journals
Aug-13-19 07:00AM  The $200K Club: NetApp's median employee gets a pay boost to join the salary ranks of Google, Netflix and Facebook American City Business Journals
Aug-09-19 09:30AM  PRGO vs. BIO: Which Stock Is the Better Value Option? Zacks
Aug-02-19 09:15AM  Bio-Rad (Bio) Q2 Earnings Beat Estimates, Margins Expand Zacks +8.26%
Aug-01-19 08:26PM  Bio-Rad Laboratories Inc (BIO) (BIO-B) Q2 2019 Earnings Call Transcript Motley Fool
06:15PM  Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:15PM  Bio-Rad Reports Second-Quarter 2019 Financial Results Business Wire
Jul-30-19 12:20PM  Do Insiders Own Shares In Biome Grow Inc. (CNSX:BIO)? Simply Wall St.
Jul-25-19 10:33AM  Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-24-19 09:52PM  Delaware District Court Grants Bio-Rads Motion for Permanent Injunction Against 10X Genomics Business Wire
Jul-23-19 08:46PM  Bio-Rad to Report Second-Quarter 2019 Financial Results Business Wire
Jul-18-19 09:19AM  IVD Market Sustains Momentum: 3 Stocks in Focus Zacks
Jul-15-19 09:12AM  ABT or BIO: Which Stock Has Better Potential Right Now? Zacks
Jul-08-19 07:30AM  Facebook churns out a per-employee profit of $635K per year. How that compares with Apple, Google, Cisco, Oracle, Salesforce and others American City Business Journals
Jul-04-19 09:06AM  Here's Why You Should Invest in CONMED (CNMD) Stock Now Zacks
Jul-03-19 09:41AM  Luminex (LMNX) Presents ARIES MRSA Assay to FDA for Clearance Zacks
Jul-01-19 05:43PM  Bio-Rad Laboratories, Inc. -- Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc. Moody's
Jun-27-19 07:34PM  Moodys Upgrades Bio-Rad to Baa2, Reflecting Recent Improvement in the Companys Operating Performance Business Wire
03:35PM  Bio-Rad Laboratories, Inc. -- Moody's upgrades Bio-Rad to Baa2, outlook is stable Moody's
Jun-14-19 08:29AM  Heres What Hedge Funds Think About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
06:53AM  What Kind Of Shareholder Appears On The BIOTON S.A.'s (WSE:BIO) Shareholder Register? Simply Wall St.
Jun-12-19 07:30AM  9 major Bay Area tech employers pay a typical worker more than $200K per year American City Business Journals
Jun-07-19 09:30AM  Bio-Rad (BIO) Down 6.9% Since Last Earnings Report: Can It Rebound? Zacks
Jun-03-19 02:03PM  Bio-Rad to Participate in Goldman Sachs Annual Global Healthcare Conference on June 11 Business Wire
May-31-19 08:09AM  Here's Why You Should Retain Bio-Rad (BIO) Stock For Now Zacks
May-24-19 12:00PM  When Will Biome Grow Inc. (CNSX:BIO) Become Profitable? Simply Wall St.
May-23-19 04:09PM  Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4 Business Wire
May-17-19 08:18AM  Edited Transcript of BIO earnings conference call or presentation 8-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-09-19 09:03AM  Bio-Rad (BIO) Q1 Earnings Beat Estimates, Margins Expand Zacks
May-08-19 08:23PM  Bio-Rad Laboratories Inc (BIO) Q1 2019 Earnings Call Transcript Motley Fool
07:05PM  Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates Zacks
06:00PM  Bio-Rad: 1Q Earnings Snapshot Associated Press
04:15PM  Bio-Rad Reports First Quarter 2019 Financial Results Business Wire
May-07-19 10:38AM  Will Life Sciences Sales Boost Bio-Rad's (BIO) Q1 Earnings? Zacks
07:30AM  Netflix and Google now pay a typical employee more than $200K per year. Here's how that compares to Facebook, Intel, Twitter and other big Bay Area tech employers. American City Business Journals
May-01-19 10:33AM  Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-25-19 12:05PM  CONMED (CNMD) Beats on Q1 Earnings, Raises '19 Guidance Zacks
11:20AM  Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates Zacks
04:10AM  Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised Zacks
Apr-24-19 11:37AM  Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View Zacks
11:35AM  Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View Zacks
10:40AM  Accuray (ARAY) Q3 Earnings Top Estimates, Gross Orders Rise Zacks
10:23AM  Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates Zacks
10:11AM  Stryker (SYK) Q1 Earnings Beat Estimates, Revenues In Line Zacks
Apr-23-19 04:15PM  Bio-Rad to Participate in the Bank of America Merrill Lynch Health Care Conference 2019 in May Business Wire
10:58AM  Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down Zacks
Apr-22-19 05:00PM  Bio-Rad Appoints Andrew Last as Executive Vice President and Chief Operating Officer Business Wire
Apr-20-19 01:02PM  Is Bio-Rad Laboratories, Inc. (BIO) A Good Stock To Buy? Insider Monkey
Apr-17-19 11:54AM  Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid Zacks
Apr-15-19 07:03PM  Bio-Rad to Report First-Quarter 2019 Financial Results Business Wire
Apr-12-19 09:45AM  Weekly Jobless Claims Lowest in Nearly 50 Years: 5 Top Picks Zacks
Apr-10-19 07:25AM  FireEye joins major Bay Area employers like Facebook, Netflix, Google, Microsoft and Salesforce in paying a typical worker more than $150,000 per year American City Business Journals
Apr-09-19 09:13AM  Bio-Rad's (BIO) IH-500 System Secures 510(K) From the FDA Zacks
07:30AM  Dow Jones Futures: Zogenix Leads 3 Big Movers On FDA News Investor's Business Daily
Apr-08-19 04:15PM  Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood Testing Market Business Wire
Apr-03-19 09:10AM  Bio-Rad's Latest FDA Nod to Boost Clinical Diagnostics Arm Zacks
Apr-02-19 05:00PM  Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer Business Wire
09:56AM  Elon Musks CEO pay-to-worker ratio is the highest ever recorded how it compares at other tech companies American City Business Journals
08:30AM  Bio-Rad Announces Innovative Test to Aid in the Diagnosis of Lyme Disease with the FDA Clearance of the BioPlex 2200 Lyme Total Assay Business Wire
Mar-30-19 09:30AM  Why Is Bio-Rad (BIO) Up 12.8% Since Last Earnings Report? Zacks
Mar-27-19 07:25AM  Recent Analysis Shows Transocean, Chipotle Mexican Grill, Marathon Oil, Laboratory Corporation of America, Bio-Rad Laboratories, and Graco Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Mar-25-19 05:00PM  Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form 10-K Filing Business Wire
Mar-22-19 08:41AM  GBT Reports Fourth Quarter and 2018 Results PR Newswire
Mar-21-19 10:25AM  Top Ranked Momentum Stocks to Buy for March 21st Zacks
Mar-15-19 10:03AM  Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks
09:38AM  Looking for a Growth Stock? Why It is Time to Focus on Bio-Rad (BIO) Zacks
08:31AM  BD's Venovo Gets FDA Nod, Interventional Arm to Get a Boost Zacks
Mar-14-19 08:38AM  Here's Why You Should Invest in Stryker (SYK) Stock Right Now Zacks
08:36AM  HEXO Catches Eye: Stock Jumps 6.6% Zacks
Mar-12-19 08:45AM  Here is Why Growth Investors Should Buy Bio-Rad (BIO) Now Zacks
06:35AM  Will Bio-Rad Laboratories Continue to Surge Higher? Zacks
Mar-11-19 09:15AM  Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Mar-06-19 10:12AM  What Makes Bio-Rad (BIO) a New Strong Buy Stock Zacks
Mar-05-19 10:02PM  Edited Transcript of BIO earnings conference call or presentation 28-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
07:30AM  The $200K Club: Broadcom joins these Bay Area tech companies paying a typical employee top dollar American City Business Journals
Mar-01-19 08:50AM  The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis Benzinga +17.17%
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STARK JAMES RVP, Corporate ControllerNov 11Sale351.45848298,0300Nov 12 11:33 AM
HERTIA JOHNExecutive Vice PresidentSep 12Option Exercise129.551,200155,46019,566Sep 13 11:54 AM
TUMOLO ANNETTEExecutive Vice PresidentSep 12Sale330.00522172,2602,410Sep 16 06:05 PM
HERTIA JOHNExecutive Vice PresidentSep 12Sale328.29838275,10418,728Sep 13 11:54 AM
TUMOLO ANNETTEExecutive Vice PresidentSep 11Option Exercise0.0060003,170Sep 12 04:29 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 11Option Exercise0.003,2000281,529Sep 12 04:24 PM
STARK JAMES RVP, Corporate ControllerSep 11Option Exercise0.003000952Sep 12 04:19 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 11Option Exercise0.00500015,065Sep 12 04:15 PM
HUTTON RONALD WVice President and TreasurerSep 11Option Exercise0.0015004,619Sep 12 04:12 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 11Option Exercise0.0060004,041Sep 12 03:59 PM
HERTIA JOHNExecutive Vice PresidentSep 11Option Exercise0.00600018,664Sep 13 11:48 AM
TUMOLO ANNETTEExecutive Vice PresidentSep 10Option Exercise0.0040002,709Sep 12 04:29 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 10Option Exercise0.002,0000279,321Sep 12 04:24 PM
STARK JAMES RVP, Corporate ControllerSep 10Option Exercise0.002000722Sep 12 04:19 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 10Option Exercise0.00400014,764Sep 12 04:15 PM
HUTTON RONALD WVice President and TreasurerSep 10Option Exercise0.0015004,521Sep 12 04:12 PM
HERTIA JOHNExecutive Vice PresidentSep 10Option Exercise0.00600018,362Sep 12 04:07 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 10Option Exercise0.0038903,576Sep 12 03:59 PM
HERTIA JOHNExecutive Vice PresidentSep 09Option Exercise159.3260095,59218,206Sep 10 05:15 PM
HERTIA JOHNExecutive Vice PresidentSep 09Sale336.47444149,39317,762Sep 10 05:15 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 08Option Exercise0.00400014,563Sep 09 06:27 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 07Option Exercise0.003,0000278,809Sep 10 02:04 PM
HUTTON RONALD WVice President and TreasurerSep 07Option Exercise0.0017004,430Sep 09 06:11 PM
HERTIA JOHNExecutive Vice PresidentSep 07Option Exercise0.00600017,904Sep 09 05:50 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 07Option Exercise0.0060002,517Sep 09 05:36 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 07Option Exercise0.0060003,395Sep 09 05:17 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 07Option Exercise0.0050001,257Sep 09 05:08 PM
STARK JAMES RVP, Corporate ControllerSep 07Option Exercise0.003000626Sep 09 03:45 PM
HERTIA JOHNExecutive Vice PresidentSep 06Option Exercise164.477,2001,184,15422,499Sep 09 05:50 PM
HERTIA JOHNExecutive Vice PresidentSep 06Sale336.575,1951,748,49017,304Sep 09 05:50 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 06Sale340.00371126,1401,917Sep 09 05:36 PM
HUTTON RONALD WVice President and TreasurerSep 05Option Exercise0.0018004,323Sep 09 06:11 PM
HERTIA JOHNExecutive Vice PresidentSep 05Option Exercise0.00600015,507Sep 09 05:50 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 05Option Exercise0.0060002,496Sep 09 05:36 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 05Option Exercise0.0060003,003Sep 09 05:17 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 05Option Exercise0.005000930Sep 09 05:08 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 05Option Exercise0.002,6000416,472Sep 09 03:49 PM
STARK JAMES RVP, Corporate ControllerSep 05Option Exercise0.003000430Sep 09 03:45 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 05Option Exercise0.00500014,411Sep 09 03:40 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 04Option Exercise0.0060002,611Sep 05 02:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 04Option Exercise0.005000603Sep 05 02:04 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 04Option Exercise0.0060002,104Sep 05 02:52 PM
HERTIA JOHNExecutive Vice PresidentSep 04Option Exercise0.00600015,115Sep 05 05:26 PM
STARK JAMES RVP, Corporate ControllerSep 04Option Exercise0.002000200Sep 05 02:22 PM
SCHWARTZ NORMAN DChairman, President and CEOSep 04Option Exercise0.002,6000415,162Sep 05 02:17 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 04Option Exercise0.00500014,117Sep 05 02:11 PM
HUTTON RONALD WVice President and TreasurerSep 04Option Exercise0.0018004,206Sep 05 02:07 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 04Sale333.081,089362,7232,011Sep 05 02:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecAug 14Sale320.0031099,200103Aug 14 05:51 PM
Crowley MichaelEVP, GBL Commercial OperationsAug 14Sale320.00325104,0003,100Aug 14 05:46 PM
ERNST TIMOTHY SEVP, General Counsel & SecMay 16Sale299.24501149,837390May 16 07:01 PM
Magni GiovanniEVP, Chief Strategy OfficerMay 15Option Exercise74.273,500259,94515,420May 15 07:03 PM
ERNST TIMOTHY SEVP, General Counsel & SecMay 15Sale290.00345100,050891May 16 07:01 PM
SCHWARTZ NORMAN DChairman, President and CEOMay 13Option Exercise75.3837,0002,789,060298,642May 13 08:12 PM
Crowley MichaelEVP, GBL Commercial OperationsDec 14Sale248.0339297,2283,425Dec 14 07:00 PM
TSINGOS CHRISTINE AEVP and CFODec 14Sale248.001,411349,9286,683Dec 17 11:20 AM
STARK JAMES RVP, Corporate ControllerDec 12Sale254.77848216,0450Dec 12 05:16 PM
TUMOLO ANNETTEExecutive Vice PresidentDec 11Option Exercise159.321,200191,1842,704Dec 12 05:07 PM
TUMOLO ANNETTEExecutive Vice PresidentDec 11Sale254.512,376604,7041,504Dec 12 05:07 PM
open in yahoo | open in reuters | open in google